Literature DB >> 1722206

An induced mRNA secondary structure enhances repZ translation in plasmid ColIb-P9.

K Asano1, H Moriwaki, K Mizobuchi.   

Abstract

Translation of the repZ gene encoding a DNA replication initiation protein of plasmid ColIb-P9 depends on not only the translation of a transcribed leader sequence (repY) but also the specific intergenic base pairing within RepZ mRNA between two short complementary sequences located in the repY and inc gene regions. In addition, repZ translation can be negatively regulated by Inc RNA, the product of the inc gene and a countertranscript to RepZ mRNA. Here we present evidence indicating that a stable secondary structure of RepZ mRNA, designated as structure III, sequesters one of the complementary sequences and the ribosome-binding site, thereby preventing repZ translation. When site-directed mutagenesis was used to destabilize structure III without changing the ribosome-binding site, a significant level of repZ expression was observed even in the absence of repY translation. Under these conditions, however, repZ expression could be substantially reduced by additional mutations that directly diminished the intergenic base pairing at the mRNA level between the two complementary sequences. These results indicate that repY translation is essential for the disruption of structure III by inducing the formation of a new secondary structure through the intergenic base pairing, and more importantly, that this new structure enhances repZ translation. We also found that the site of repY translation termination played a critical role in the intramolecular conformational alteration of structure III.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1722206

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Analysis of elements involved in pseudoknot-dependent expression and regulation of the repA gene of an IncL/M plasmid.

Authors:  V Athanasopoulos; J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

2.  Pseudoknot-dependent translational coupling in repBA genes of the IncB plasmid pMU720 involves reinitiation.

Authors:  J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  2002-10       Impact factor: 3.490

3.  Replication control of staphylococcal multiresistance plasmid pSK41: an antisense RNA mediates dual-level regulation of Rep expression.

Authors:  Stephen M Kwong; Ronald A Skurray; Neville Firth
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

4.  Bulged-out nucleotides in an antisense RNA are required for rapid target RNA binding in vitro and inhibition in vivo.

Authors:  T A Hjalt; E G Wagner
Journal:  Nucleic Acids Res       Date:  1995-02-25       Impact factor: 16.971

5.  The replication of an IncL/M plasmid is subject to antisense control.

Authors:  V Athanasopoulos; J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

6.  Control of ColE2 DNA replication: in vitro binding of the antisense RNA to the Rep mRNA.

Authors:  T Sugiyama; T Itoh
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

7.  Mutations affecting pseudoknot control of the replication of B group plasmids.

Authors:  I W Wilson; J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1993-10       Impact factor: 3.490

8.  Importance of structural differences between complementary RNA molecules to control of replication of an IncB plasmid.

Authors:  I W Wilson; K R Siemering; J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1997-02       Impact factor: 3.490

9.  Role of CIS in replication of an IncB plasmid.

Authors:  J Praszkier; A J Pittard
Journal:  J Bacteriol       Date:  1999-05       Impact factor: 3.490

10.  Interaction of the initiator protein of an IncB plasmid with its origin of DNA replication.

Authors:  T Betteridge; J Yang; A J Pittard; J Praszkier
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.